We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$260M
AUM Growth
-$12.2M
Cap. Flow
-$4.07M
Cap. Flow %
-1.56%
Top 10 Hldgs %
49.51%
Holding
34
New
1
Increased
Reduced
27
Closed
2

Sector Composition

1 Technology 19.3%
2 Industrials 17.47%
3 Healthcare 15.47%
4 Consumer Discretionary 14.84%
5 Financials 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCC
1
WESCO International
WCC
$15.9B
$15.1M 5.78%
130,575
-218
-0.2% -$24K
MCHP icon
2
Microchip Technology
MCHP
$44.4B
$14.6M 5.59%
189,822
-360
-0.2% -$27K
RUSHA icon
3
Rush Enterprises Class A
RUSHA
$6.19B
$14.3M 5.51%
476,567
MCK icon
4
McKesson
MCK
$98.5B
$13.1M 5.02%
65,548
-83
-0.1% -$16.6K
BFH icon
5
Bread Financial
BFH
$3.97B
$12.6M 4.84%
156,525
-269
-0.2% -$20.8K
MSFT icon
6
Microsoft
MSFT
$2.98T
$12.6M 4.84%
44,701
-75
-0.2% -$21.8K
DOW icon
7
Dow Inc
DOW
$21.1B
$12.5M 4.8%
217,319
-393
-0.2% -$24.1K
AVGO icon
8
Broadcom
AVGO
$1.78T
$11.8M 4.54%
243,700
-410
-0.2% -$19.9K
AAPL icon
9
Apple
AAPL
$4.89T
$11.3M 4.33%
79,609
-133
-0.2% -$19.6K
MTZ icon
10
MasTec
MTZ
$26.9B
$11.1M 4.26%
128,634
-541
-0.4% -$51.3K
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$10.1M 3.88%
36,975
-58
-0.2% -$16.3K
UNH icon
12
UnitedHealth
UNH
$384B
$9.54M 3.66%
24,412
-41
-0.2% -$17K
MTH icon
13
Meritage Homes
MTH
$5.17B
$9.37M 3.6%
193,274
-328
-0.2% -$16.9K
AMLP icon
14
Alerian MLP ETF
AMLP
$12.7B
$9.35M 3.59%
280,436
-451
-0.2% -$15.1K
CVS icon
15
CVS Health
CVS
$136B
$9.22M 3.54%
108,645
-189
-0.2% -$15.8K
SLB icon
16
SLB Ltd
SLB
$70.4B
$9.2M 3.53%
310,376
-525
-0.2% -$15K
TEN
17
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$8.21M 3.15%
575,419
-952
-0.2% -$15.3K
CCJ icon
18
Cameco
CCJ
$38B
$8.17M 3.14%
375,775
-3,810
-1% -$72.1K
KEX icon
19
Kirby Corp
KEX
$7.67B
$7.91M 3.04%
164,851
-275
-0.2% -$15.2K
NMIH icon
20
NMI Holdings
NMIH
$3.23B
$7.46M 2.87%
330,061
-547
-0.2% -$12K
BMY icon
21
Bristol-Myers Squibb
BMY
$124B
$7.42M 2.85%
125,419
-204
-0.2% -$13.4K
GLD icon
22
SPDR Gold Trust
GLD
$130B
$6.82M 2.62%
41,512
-125
-0.3% -$20.9K
LMT icon
23
Lockheed Martin
LMT
$118B
$6.67M 2.56%
19,319
-30
-0.2% -$10.9K
LEN icon
24
Lennar Class A
LEN
$20.8B
$6.4M 2.46%
70,548
-117
-0.2% -$11.6K
WAB icon
25
Wabtec
WAB
$44.8B
$4.76M 1.83%
55,276
-82
-0.1% -$7.06K

Similar funds

Muhlenkamp & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Muhlenkamp & Co held 34 positions worth $260M, down 4.5% from $273M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Muhlenkamp & Co's Q3 2021 filing shows 1 new, 27 reduced and 2 closed positions. Its largest new stake was Equity Commonwealth: 112,943 shares worth $2.93M. The largest sale was Biogen, an estimated $6.31M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Muhlenkamp & Co's largest Q3 2021 buy was Equity Commonwealth: 112,943 shares worth $2.93M.
  • Muhlenkamp & Co's biggest Q3 2021 reduction was Cameco, cutting an estimated $72.1K.
  • Muhlenkamp & Co fully exited Biogen in Q3 2021, selling an estimated $6.31M.
  • Muhlenkamp & Co's ten largest holdings make up 50% of its $260M portfolio in Q3 2021.
  • Muhlenkamp & Co opened 1 new position and closed 2 in Q3 2021.
  • Muhlenkamp & Co's portfolio value fell 4.5% quarter-over-quarter to $260M.

Based on Muhlenkamp & Co's 13F filing for Q3 2021, filed 10 Dec 2021.